Cited by 988

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA

Fonfara, Ines, Richter, Hagen, Bratovič, Majda, Le Rhun, Anaïs, Charpentier, Emmanuelle·2016·Nature

Abstract

CRISPR-Cas systems that provide defence against mobile genetic elements in bacteria and archaea have evolved a variety of mechanisms to target and cleave RNA or DNA. The well-studied types I, II and III utilize a set of distinct CRISPR-associated (Cas) proteins for production of mature CRISPR RNAs (crRNAs) and interference with invading nucleic acids. In types I and III, Cas6 or Cas5d cleaves precursor crRNA (pre-crRNA) and the mature crRNAs then guide a complex of Cas proteins (Cascade-Cas3, type I; Csm or Cmr, type III) to target and cleave invading DNA or RNA. In type II systems, RNase III cleaves pre-crRNA base-paired with trans-activating crRNA (tracrRNA) in the presence of Cas9 (refs 13, 14). The mature tracrRNA-crRNA duplex then guides Cas9 to cleave target DNA. Here, we demonstrate a novel mechanism in CRISPR-Cas immunity. We show that type V-A Cpf1 from Francisella novicida is a dual-nuclease that is specific to crRNA biogenesis and target DNA interference. Cpf1 cleaves pre-crRNA upstream of a hairpin structure formed within the CRISPR repeats and thereby generates intermediate crRNAs that are processed further, leading to mature crRNAs. After recognition of a 5'-YTN-3' protospacer adjacent motif on the non-target DNA strand and subsequent probing for an eight-nucleotide seed sequence, Cpf1, guided by the single mature repeat-spacer crRNA, introduces double-stranded breaks in the target DNA to generate a 5' overhang. The RNase and DNase activities of Cpf1 require seq…

Overview

Integrity signals

Registry

Crossref · 10.1038/nature17945

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 39

  1. Marraffini, L. A. CRISPR-Cas immunity in prokaryotes. Nature 526, 55–61 (2015) · DOI
  2. Carte, J., Wang, R., Li, H., Terns, R. M. & Terns, M. P. Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes. Genes Dev. 22, 3489–3496 (2008) · DOI
  3. Ebihara, A. et al. Crystal structure of hypothetical protein TTHB192 from Thermus thermophilus HB8 reveals a new protein family with an RNA recognition motif-like domain. Protein Sci. 15, 1494–1499 (2006) · DOI
  4. Charpentier, E., Richter, H., van der Oost, J. & White, M. F. Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity. FEMS Microbiol. Rev. 39, 428–441 (2015) · DOI
  5. Nam, K. H. et al. Cas5d protein processes pre-crRNA and assembles into a cascade-like interference complex in subtype I–C/Dvulg CRISPR-Cas system. Structure 20, 1574–1584 (2012) · DOI
  6. Jore, M. M. et al. Structural basis for CRISPR RNA-guided DNA recognition by Cascade. Nature Struct. Mol. Biol. 18, 529–536 (2011) · DOI
  7. Mulepati, S., Heroux, A. & Bailey, S. Crystal structure of a CRISPR RNA-guided surveillance complex bound to a ssDNA target. Science 345, 1479–1484 (2014) · DOI
  8. Plagens, A., Richter, H., Charpentier, E. & Randau, L. DNA and RNA interference mechanisms by CRISPR-Cas surveillance complexes. FEMS Microbiol. Rev. 39, 442–463 (2015) · DOI
  9. van der Oost, J., Westra, E. R., Jackson, R. N. & Wiedenheft, B. Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nature Rev. Microbiol. 12, 479–492 (2014) · DOI
  10. Zhang, J. et al. Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity. Mol. Cell 45, 303–313 (2012) · DOI
  11. Staals, R. H. et al. RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus . Mol. Cell 56, 518–530 (2014) · DOI
  12. Samai, P. et al. Co-transcriptional DNA and RNA cleavage during type III CRISPR-Cas immunity. Cell 161, 1164–1174 (2015) · DOI · Paper page
  13. Chylinski, K., Le Rhun, A. & Charpentier, E. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. RNA Biol. 10, 726–737 (2013) · DOI · Paper page
  14. Zetsche, B. et al. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163, 759–771 (2015) · DOI · Paper page
  15. Schunder, E., Rydzewski, K., Grunow, R. & Heuner, K. First indication for a functional CRISPR/Cas system in Francisella tularensis . Int. J. Med. Microbiol. 303, 51–60 (2013) · DOI
  16. Makarova, K. S. et al. An updated evolutionary classification of CRISPR-Cas systems. Nature Rev. Microbiol. 13, 722–736 (2015) · DOI · Paper page
  17. Shmakov, S. et al. Discovery and functional characterization of diverse class 2 CRISPR-Cas systems. Mol. Cell 60, 385–397 (2015) · DOI · Paper page
  18. Haurwitz, R. E., Jinek, M., Wiedenheft, B., Zhou, K. & Doudna, J. A. Sequence- and structure-specific RNA processing by a CRISPR endonuclease. Science 329, 1355–1358 (2010) · DOI
  19. Dong, D. et al. The crystal structure of Cpf1 in complex with CRISPR RNA. Nature http://dx.doi.org/10.1038/nature17944 (20 April 2016) · DOI · Paper page
  20. Jiang, F., Zhou, K., Ma, L., Gressel, S. & Doudna, J. A. A. Cas9-guide RNA complex preorganized for target DNA recognition. Science 348, 1477–1481 (2015) · DOI
  21. Sternberg, S. H., Redding, S., Jinek, M., Greene, E. C. & Doudna, J. A. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature 507, 62–67 (2014) · DOI · Paper page
  22. Szczelkun, M. D. et al. Direct observation of R-loop formation by single RNA-guided Cas9 and Cascade effector complexes. Proc. Natl Acad. Sci. USA 111, 9798–9803 (2014) · DOI
  23. Zhang, Y., Rajan, R., Seifert, H. S., Mondragon, A. & Sontheimer, E. J. DNase H activity of Neisseria meningitidis Cas9. Mol. Cell 60, 242–255 (2015) · DOI
  24. Yang, W. An equivalent metal ion in one- and two-metal-ion catalysis. Nature Struct. Mol. Biol. 15, 1228–1231 (2008) · DOI
  25. Vasu, K. et al. Increasing cleavage specificity and activity of restriction endonuclease KpnI. Nucleic Acids Res. 41, 9812–9824 (2013) · DOI
  26. Nam, K. H. et al. Double-stranded endonuclease activity in Bacillus halodurans clustered regularly interspaced short palindromic repeats (CRISPR)-associated Cas2 protein. J. Biol. Chem. 287, 35943–35952 (2012) · DOI
  27. Punetha, A., Sivathanu, R. & Anand, B. Active site plasticity enables metal-dependent tuning of Cas5d nuclease activity in CRISPR-Cas type I–C system. Nucleic Acids Res. 42, 3846–3856 (2014) · DOI
  28. Robinson, J. T. et al. Integrative genomics viewer. Nature Biotechnol. 29, 24–26 (2011) · DOI · Paper page
  29. Thorvaldsdóttir, H., Robinson, J. T. & Mesirov, J. P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief. Bioinform. 14, 178–192 (2013) · DOI · Paper page
  30. Sampson, J. R. & Uhlenbeck, O. C. Biochemical and physical characterization of an unmodified yeast phenylalanine transfer RNA transcribed in vitro . Proc. Natl Acad. Sci. USA 85, 1033–1037 (1988) · DOI
  31. McClelland, M., Hanish, J., Nelson, M. & Patel, Y. KGB: a single buffer for all restriction endonucleases. Nucleic Acids Res. 16, 364 (1988) · DOI
  32. Herbert, S., Barry, P. & Novick, R. P. Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus . Infect. Immun. 69, 2996–3003 (2001) · DOI
  33. Urban, J. H. & Vogel, J. Translational control and target recognition by Escherichia coli small RNAs in vivo . Nucleic Acids Res. 35, 1018–1037 (2007) · DOI
  34. Pall, G. S. & Hamilton, A. J. Improved northern blot method for enhanced detection of small RNA. Nature Protocols 3, 1077–1084 (2008) · DOI
  35. Edgar, R. C. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics 5, 113 (2004) · DOI
  36. Waterhouse, A. M., Procter, J. B., Martin, D. M., Clamp, M. & Barton, G. J. Jalview Version 2–a multiple sequence alignment editor and analysis workbench. Bioinformatics 25, 1189–1191 (2009) · DOI
  37. Robinson, J. T. et al. Integrative genomics viewer. Nature Biotechnol. 29, 24–26 (2011) · DOI · Paper page
  38. Gruber, A. R., Lorenz, R., Bernhart, S. H., Neubock, R. & Hofacker, I. L. The Vienna RNA websuite. Nucleic Acids Res. 36, 3429–3431 (2008) · DOI
  39. Darty, K., Denise, A. & Ponty, Y. VARNA: Interactive drawing and editing of the RNA secondary structure. Bioinformatics 25, 1974–1975 (2009) · DOI

Cited by

Sorted by citations

Metadata

Authors
Fonfara, I., Richter, H., Bratovič, M., Le Rhun, A., & Charpentier, E.
Venue
Nature
Published
2016-04
Volume
532
Issue
7600
Pages
517-521
ISSN
  • 0028-0836
  • 1476-4687
Cited by
988
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review